van Vliet, E., Lipovec, N. Č.
, van der Goot, M., Abtahi, S., Ribeiro-Vaz, I., Poplavska, E., Dermiki-Gkana, F., Oikonomou, C., Deligianni, E., Kontogiorgis, C., Silva, A. M., Ferreira, P. B. S., Kos, M., Almarsdóttir, A. B., Jacobsen, R., Buhl, C., de Bruijn, A., Hegger, I., & Alves, T. L. (2024).
Impact of Regulatory Risk Communication on Thrombosis With Thrombocytopenia Syndrome for COVID-19 Adenovirus Vector Vaccines on European Healthcare Professionals.
Pharmacoepidemiology and Drug Safety,
33(12), e70057.
https://doi.org/10.1002/pds.70057